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Abstract
 
Host-adapted strains of 
 
Salmonella
 
 are capable of establishing a persistent infection in their host
often in the absence of clinical disease. The mouse model of 
 
Salmonella
 
 infection has primarily
been used as a model for the acute systemic disease. Therefore, the sites of long-term 
 
S. typhi-
murium
 
 persistence in the mouse are not known nor are the mechanisms of persistent infection
 
clearly understood. Here, we show that 
 
S. typhimurium
 
 can persist for as long as 1 yr in the
 
mesenteric lymph nodes (MLNs) of 129sv 
 
Nramp1
 
 
 
/
 
 
 
 (
 
Slc11a1
 
 
 
/
 
 
 
) mice despite the presence
of high levels of anti–
 
S. typhimurium
 
 antibody. Tissues from 129sv mice colonized for 60 d
contain numerous inflammatory foci and lesions with features resembling 
 
S. typhi
 
 granulomas.
Tissues from mice infected for 365 d have very few organized inflammatory lesions, but the
bacteria continue to persist within macrophages in the MLN and the animals generally remain
 
disease-free. Finally, chronically infected mice treated with an interferon-
 
 
 
 neutralizing anti-
body exhibited symptoms of acute systemic infection, with evidence of high levels of bacterial
 
replication in most tissues and high levels of fecal shedding. Thus, interferon-
 
 
 
, which may
affect the level of macrophage activation, plays an essential role in the control of the persistent
 
S. typhimurium
 
 infection in mice.
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Introduction
 
Salmonella
 
 serovars are responsible for human diseases that
range from gastroenteritis to systemic infections. 
 
Salmonella
typhi
 
 causes human typhoid fever, whereas 
 
Salmonella typhi-
murium
 
 has a broad host range, causing disease in a variety of
animals. Strains of 
 
S. typhimurium
 
 usually cause a self-limiting
gastroenteritis in humans and a systemic typhoid-like disease
in mice. Although 
 
S. typhimurium
 
 has been widely used as an
experimental model for typhoid fever (1), there are signifi-
cant genetic differences between 
 
S. typhi
 
 and 
 
S. typhimurium
 
(2), which should be kept in mind when extrapolating
between murine and human typhoid. 
 
S. typhimurium
 
 infec-
tion of mice and 
 
S. typhi
 
 infection of humans is character-
ized by inflammation at the site of bacterial entry, typically
the Peyer’s patches (3). After 
 
Salmonella
 
 penetrates the epi-
thelial barrier, it preferentially infects phagocytes within the
lamina propria. In 
 
Salmonella
 
 gastroenteritis, the infection is
usually self-limiting and does not proceed beyond the lamina
propria. In host-adapted salmonellosis such as typhoid fever,
the 
 
Salmonella
 
-infected phagocytes gain access to the lym-
phatics and bloodstream permitting the bacteria to spread to
the liver and the spleen (4).
 
S. typhi
 
 and 
 
S. paratyphi
 
 serovars are important human
pathogens of immense public health and economic impor-
tance; moreover, they are endemic in regions of the world
 
where drinking water quality and sewage treatment facilities
are poor (5, 6). Infections remain difficult to treat by anti-
biotic therapy because the frequency of resistance to current
antibiotics is increasing (7). A significant percentage (1–6%)
of typhoid patients become chronic carriers of 
 
S. typhi
 
, as
do many people who have never had a clinical history of
typhoid fever (8–10). These individuals shed bacteria in
their stools or urine for a varying period of time ranging
from 1 yr to a lifetime without any apparent signs of disease
(11). Typhoid carriers are of special concern from a public
health viewpoint because they are the reservoirs for the
spread of infection and disease. 
 
S. typhi
 
 is carried for years,
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even in the presence of an immune response; chronic carri-
ers of 
 
S. typhi
 
 have high levels of circulating serum anti-
bodies to Vi and flagellar antigens, indicating that the or-
ganism has established a privileged niche that is sequestered
from the host’s immune defenses (5, 12). By investigating
the chronic carrier state in salmonellosis, we hope to gain
insight into bacterial strategies for survival as well as new
clues for the potential treatment approaches for typhoid
and other persistent microbial infections.
Mouse typhoid is similar to human typhoid in several
ways, and 
 
S. typhimurium
 
 infections of laboratory mouse
strains have been used successfully to study complex host–
pathogen interactions. Different strains of mice show dif-
ferent levels of susceptibility to 
 
Salmonella
 
 infection (13). In
the mouse, a significant component of the innate resis-
tance/susceptibility to infections with 
 
S. typhimurium
 
 is
controlled by the gene 
 
Nramp1
 
 (also called 
 
Slc11a1
 
; refer-
ences 14–16). Murine 
 
Nramp1
 
 expression is restricted to
cells of the monocyte/macrophage lineage and affects the
capacity of the host to control intracellular replication of
microorganisms that reside in the phagolysosome (17).
Thus, Nramp1 is involved in the control of the exponential
growth of the bacteria in the reticuloendothelial organs
during the early phase of infection (18). Susceptibility in
mice is associated with a nonconservative amino acid substi-
tution at position 169 (glycine
 
resistant
 
 to aspartic acid
 
sensitive
 
),
caused by a point mutation in the region encoding a puta-
tive transmembrane domain. Consequently, mice carrying
two copies of the 
 
Nramp1
 
Asp169
 
 allele are significantly less
resistant to lethal 
 
S. typhimurium
 
 infections compared with
mice harboring the wild-type or 
 
Nramp1
 
Gly169
 
 allele (18).
More recently, 
 
Nramp1
 
 has been implicated as being in-
volved in influencing the clearance of 
 
Salmonella enteritidis
 
during the acquired immunity phase of infection by an un-
determined mechanism (19).
The control of 
 
Salmonella
 
 clearance during the late phase
of infection appears to be influenced by various loci
through their effects on the acquired immune response.
The MHC of the mouse (also named H2) plays an impor-
tant role in the clearance of 
 
Salmonella
 
 during the late phase
of infection (13, 20). Likewise in humans, a genetic link
between specific Class II and Class III MHC haplotypes
and relative resistance to 
 
S. typhi
 
 has been demonstrated
(21). Several studies have shown a requirement for both
CD4
 
 
 
 and CD8
 
 
 
 T-lymphocytes for clearance of 
 
Salmo-
nella
 
 infections (22–24). The humoral response is also in-
volved in the clearance of 
 
Salmonella
 
. Mice carrying a
mutation in the 
 
Btk
 
 gene (or xid [X-linked immunodefi-
ciency]) possess a defect in peripheral B cell activation that
results in deficient antibody production and the inability to
clear 
 
Salmonella
 
 infection (25, 26).
Most investigations of 
 
Salmonella
 
 pathogenesis have his-
torically used 
 
Salmonella
 
-sensitive mice. This reflects, in
part, the convenience of death or pathology as an experi-
mental endpoint that could be readily quantitated. Thus,
acute 
 
S.
 
 
 
typhimurium
 
 infections have been well character-
ized in this model. However, this model is not suitable for
 
long-term carriage studies, as the mice either die rapidly
from relatively low doses of 
 
Salmonella
 
 or clear the bacteria.
Previous studies using mutant 
 
S. typhimurium
 
 strains in sus-
ceptible strains of mice have shown that these mutants can
colonize mice for as long as 2 mo (27–29). Although these
models are useful for understanding the development of
protective immunity to 
 
Salmonella
 
, they do not always con-
tribute to an understanding of the pathogenesis of persistent
 
Salmonella
 
 infections with wild-type bacteria.
We have explored a typhoid model of infection using
mice carrying the wild-type 
 
Nramp1
 
 allele infected orally
with a wild-type 
 
S. typhimurium
 
 strain. In this experimental
model of infection, we have determined that 
 
Salmonella
 
 is
carried chronically in the reticuloendothelial system (RES)
as long as 1 yr after infection. We further found that bacte-
ria persisting in the host were most often sequestered
within macrophages of the mesenteric LNs (MLNs). We
have shown that IFN
 
 
 
 is essential for the control of persis-
tent 
 
S. typhimurium
 
 infection.
 
Materials and Methods
 
Bacterial Strains and Growth Conditions.
 
SL1344, a wild-type
 
S. typhimurium 
 
strain, was obtained from B.A.D. Stocker (Stan-
ford University). SMB500 (SL1344
 
hha
 
::Tn5
 
lux
 
) was obtained
from S. Burns (Stanford University). SMB500 contains the 
 
lux-
CDABE
 
 genes, which are required for the production of biolu-
minescent light, constitutively expressed from the prokaryotic
EM7 promoter (InvivoGen). Bacteria were grown overnight
with aeration in Luria broth before oral inoculation of mice. The
bacteria were washed and resuspended with PBS to the appropri-
ate concentration.
 
Mice and S. typhimurium Infections.
 
8–10-wk-old 129sv H-2
 
b
 
Nramp1
 
 
 
/
 
 
 
 (Jackson Laboratories) and C57BL/6 H-2
 
b
 
Nramp1
 
Asp169/Asp169
 
 (Jackson Laboratories) mice were kept under
specific pathogen-free conditions in filter-top cages. Mice were
provided with sterile water and food ad libitum.
Mice were deprived of food 14 h before orogastric inocula-
tion. For LD
 
50
 
 calculations, 35 129sv and 35 C57BL/6 mice were
inoculated through a gastric tube, with serial 10-fold (
 
n
 
 
 
 
 
 5
mice/inoculum) dilutions ranging from 1.38 
 
 
 
 10
 
4
 
 to 1.38 
 
 
 
10
 
10
 
 CFU in a volume of 0.1 ml. The health of the animals was
monitored for 30 d after inoculation, and deaths were recorded.
Mice were monitored for shedding of 
 
S. typhimurium
 
 in feces by
collecting an average of 0.1 g of fresh fecal pellets from each indi-
vidual mouse. The pellets were homogenized in PBS and 9/10
was plated directly, and 1/10 of the volume was incubated for
18 h in selenite broth. Both were plated on XLD (Oxoid) plates
containing 200 
 
 
 
g/ml streptomycin to obtain CFU per gram of
feces. For colonization experiments, mice were inoculated oro-
gastrically with the indicated dose of wild-type 
 
S. typhimurium
 
SL1344. Mice were bled before being killed on days 5 (
 
n
 
 
 
  
 
3), 60
(
 
n
 
 
 
  
 
5), 140 (n   4), 180 (n   5), 270 (n   5), and 365 (n   13)
followed by dissection of cecum, PP, MLN, liver, gallbladder,
and spleen. Tissues were homogenized and weighed, and dilu-
tions were plated on Luria agar plates containing 200  g/ml
streptomycin to obtain CFU per gram of tissue.
Neutralization of IFN  in Infected Mice. 10 mice were inocu-
lated as described in the previous paragraph and kept in separate
cages for 260 d. Mice were injected intraperitoneally with 200  gMonack et al. 233
of either an anti-IFN  neutralizing antibody or an isotype-
matched control antibody (both provided by N.F. Landolfi, Pro-
tein Design Laboratories, Fremont, CA). The half-life of the anti-
IFN  and isotype-matched control antibodies is on the order of
14–18 d (Landolfi, N.F., personal communication). The mice
were given two boosts of 200  g of antibody on days 7 and 14 af-
ter the initial injection.
Anti-Salmonella Serum IgG Response. The serum IgG response
to  S. typhimurium was determined by ELISA using sonicated-
killed S. typhimurium as coating antigen as described by Barrow et
al. (30). The titer was determined as the highest dilution of serum
to give an optical density reading above background.
In Vivo Bioluminescent Imaging. The group of mice that were
infected with the SL1344::lux strain were monitored for bacterial
counts at 7, 23, 40, and 80 d after infection with an in vivo imag-
ing system (IVIS). Mice were anesthetized with 70 mg/kg pento-
barbital and imaged as described previously (31). At the time of
imaging, mice were placed in an IVIS equipped with a cooled
CCD camera and lens (model Navitar f 0.9; Xenogen Corp.). A
grayscale reference image was first taken under weak illumination
followed by a 5-min image of the light that was transmitted
through the animal’s tissues. After photon collection, a pseudo-
color representation of light intensity (red, most intense; blue, least
intense) was superimposed over the grayscale body surface refer-
ence image. Data acquisition and analyses were performed using
the LivingImage software (Xenogen Corp.) that runs as an overlay
on the image analysis package (IgorPro; Wavemetrics).
Histology and Immunohistochemistry of Tissue Sections. For his-
tological examinations on tissue sections, tissues were fixed in
10% buffered neutral formalin, embedded in paraffin, and serially
sectioned. Some sections were stained with hematoxylin and
eosin. MLN for immunohistochemistry was embedded in OCT
and 15–20- m frozen sections were cut on a cryostat. The sec-
tions were incubated in anti-Salmonella polyclonal rabbit antise-
rum (diluted 1:1,000) and a biotinylated pan-macrophage anti-
body MOMA-2 (diluted 1:10; Serotec), or a biotinylated
neutrophil antibody (Gr-1; BD Biosciences), in PBS containing
3% BSA and 0.2% saponin. Next, tissue sections were incubated
with anti–rabbit-Alexa488 antibody (Molecular Probes), strepta-
vidin-Alexa594 (Molecular Probes), and either an anti–mouse
IgG-Alexa660 antibody, a B cell antibody (B220) conjugated to
Cy5, or ToTo-3 (Molecular Probes) to stain host cell nuclei.
Coverslips were mounted over antiquench (Vector Laboratories)
and sealed.
CLSM and Image Analysis. The images were collected on a
microscope (model Optiphot-2; Nikon) attached to a confocal la-
ser scanning microscope (model MRC1024; Bio-Rad Laborato-
ries) using LaserSharp software (Bio-Rad Laboratories). The laser
lines on the krypton/argon laser were 488 nm (Alexa488), 568
nm (Alexa594), and 647 nm (Alexa660 and TOTO3). The nu-
merical aperture was 0.75 on the 60  oil objective. Volocity 2.0
(Improvision Inc.) was used for image analysis, and all images
were based on maximum intensity projection.
Results
129sv Mice Are Colonized Systemically and Are Resistant to
Death after Oral Inoculation with Wild-type S. typhimurium.
Previous studies of Salmonella infections in mice carrying a
wild-type Nramp1 allele were performed by infecting mice
either intravenously or intraperitoneally (18, 19, 32–36). In
contrast, naturally acquired systemic Salmonella infections
occur via the entry of a few bacteria from the gastrointesti-
nal tract into tissue via systemic circulation (4, 37). Thus,
we characterized the course of infection and colonization
in Nramp1 wild-type mice (129sv) after an oral inocula-
tion with 106 CFU of a wild-type S. typhimurium strain
(SL1344) and compared this with mice carrying a mutant
Nramp1 allele (C57BL/6). Both C57BL/6 and 129sv mice
were colonized to similar levels in the cecum, PP, MLN,
and spleen 5 d after oral inoculation (unpublished data), in-
dicating S. typhimurium could establish the initial steps of a
systemic infection in both mouse strains. However, by day
5, C57BL/6 mice showed signs of illness, such as ruffled fur
and malaise, whereas the 129sv mice had no apparent signs
of illness. We determined the oral LD50 of both strains of
mice and found that there were dramatic differences. The
oral LD50 in C57BL/6 mice was 2.4   105 CFU, whereas
the oral LD50 in 129sv mice was  109 CFU, as only two of
the five mice died when the highest dose tested, 109 CFU,
was administered.
Model of Chronic S. typhimurium Infection in 129sv Mice.
Based on the aforementioned observations and work from
a previous study (19), in which a strain of S. enteritidis was
carried in the spleens of 129sv mice for 42 wk after an in-
Figure 1. Systemic infections in 129sv mice induce splenomegaly and
enlarged MLN. (A) The spleen from an uninfected age-matched 129sv
mouse on the left is shown next to the spleen from a 129sv mouse (spleen
on the right) infected with SL1344 for 60 d. (B) MLN from the same
mice as in A (right, infected MLN). (C) The weights of the spleens are
plotted on the y axis, with time from infection on the x axis. Infected
spleens weighed significantly more than the uninfected control spleens.
P   0.0001 for day 30; P   0.01 for day 140; P   0.01 for day 365 (n  
5 for each day).S. typhimurium Reactivation in Chronically Infected Mice 234
travenous inoculation with 103 organisms, we reasoned that
this mouse line might prove extremely useful as a model to
study the pathogenesis of long-term S. typhimurium infec-
tion in a mammalian host. Thus, we inoculated 35 129sv
mice orally with 108 CFU of a wild-type S. typhimurium
strain (SL1344) and monitored tissue colonization, fecal
shedding, and tissue pathology over the course of 1 yr.
At early times after infection, most of the mice showed
histopathological lesions characteristic of S. typhimurium in
the spleen, liver, PP, and MLN, which was indicative of an
acute infection. The number and severity of lesions and the
weights of infected spleens decreased with time (Fig. 1 C),
which was indicative of convalescence. 3 of the 35 mice
died over the course of the experiment, on day 165, 280,
and 295, respectively, after infection; at postmortem, these
mice cultured positive in the cecum, MLN, spleen, and
liver for S. typhimurium (not depicted).
S. typhimurium infection of 129sv mice induced pro-
nounced splenomegaly (Fig. 1 A) and enlarged MLNs (Fig.
1 B), which peaked after 30–40 d and persisted for several
weeks (Fig. 1 C). Spleen sizes slowly returned to a more
normal size; however, there was a small, but significant in-
crease in spleen weight compared with age-matched unin-
fected control spleens at 140 and 365 d after infection (Fig.
1 C). Despite the chronic presence of bacteria, most of the
mice did not display any signs of acute illness such as mal-
aise, weight loss, or ruffled fur. At 60 d, we found that the
mice were still colonized at systemic sites (Table I). Al-
though all five of the mice killed at 60 d were colonized,
the bacterial burden per gram of tissue was considerably
lower than mice infected for 5 d. In addition, we found
some variation in the presence of S. typhimurium in different
tissues: all of the mice were colonized in the MLN at 60 d;
and two mice were colonized in all of the tissues tested.
Three mice were shedding S. typhimurium in the feces on
day 60; the presence of S. typhimurium in the feces corre-
lated with gall bladder and cecal colonization (Table I).
When we monitored additional mice for fecal shedding on
four consecutive days (114–117 d after infection), we found
that shedding varied from day to day in individual mice
(Fig. 2), suggesting that shedding occurs in periodic waves
as Salmonella replicates. This result is similar to what has
been well documented for human typhoid carriers (38–40).
At 140 and 180 d after infection, there was no increase in
the overall bacterial burden per gram of tissue (2–3 logs per
gram of tissue; Table I); however, the number of mice that
Figure 2. Shedding of S. typhimurium in feces from persistently infected
129sv mice. A mean of 0.1 g of feces was collected from five different
mice on days 114–117 after infection with SL1344. The contents were
homogenized and plated on XLD plates. The CFU per gram of feces varied
from day-to-day in a given mouse.
Table I. Log10 CFU Per Gram of Tissues after Oral Infection of 
129sv Mice with 108 SL1344
Day Mouse Feces Cecum PP MLN Spleen Liver
Gall
bladder
60 1 – – – 2.18 2.31 0.75 –
2 4.60 3.55 2.51 2.98 2.72 1.88 2.67
3 5.10 1.18 – 2.94 2.37 1.25 1.84
4 3.16 2.54 1.36 2.73 2.59 1.96 1.51
5 – – – 3.69 – – –
140 1 – – – 3.88 – – –
2 – 1.18 – 2.98 2.31 0.75 –
3 – – – 3.56 – – –
4 – 1.97 2.69 2.87 2.43 1.66 –
5 – – – 2.19 1.96 1.31 2.40
180 1 – 2.38 – 3.86 1.18 1.16 –
2 – – – 2.04 – – –
3 – – – 2.35 2.11 2.10 2.52
4 2.98 4.29 – 3.15 1.74 1.94 2.46
270 1 – – – 2.42 – – –
2––– ––––
3 – – – 3.72 1.16 – –
4 – – – 3.22 – – –
5 – – – 2.65 – – –
365 1 – – – 3.27 – – –
2 – – – 4.42 – – –
3 – – – 4.38 – – –
4 – – – 2.41 – – –
5––– ––––
6––– ––––
7 – – – 3.38 – – –
8––– ––––
9a 4.16 4.89 4.81 4.50 1.16 2.43 3.73
10 – – – – – – –
11 – – – 2.97 2.94 2.01 –
12 – – – – – – –
13 – – – 2.54 2.93 1.80 2.07
aMouse had signs of illness such as ruffled fur and malaise.Monack et al. 235
were colonized in the intestinal sites, cecum, and PP, de-
creased. In contrast, all of the mice continued to be colo-
nized in the RES, MLN, and/or spleen. Only one of the
mice sampled at 180 d after infection was shedding; this an-
imal was colonized in the cecum and gall bladder.
By 270 days, four of the five mice sampled were persis-
tently infected in the MLN. One mouse, although it had
been previously infected as indicated by the presence of S.
typhimurium in the feces at 60 d after infection, appeared to
have cleared the infection (Table I). The overall bacterial
burden in the MLN did not change dramatically compared
with the earlier time points. By 365 d, 5 of the remaining
13 mice had cleared the infection, although they had previ-
ously been shedding S. typhimurium at 60 d after infection,
and 1 mouse at the time of sampling exhibited clear symp-
toms of illness and was colonized by S. typhimurium in all
tissues tested (Table I). All eight of the persistently infected
mice sampled 1 yr after infection were still infected in the
MLN, with a range of 2–5 logs CFU per gram of tissue
(Table I). These data indicate that after the early or acute
phase of a systemic Salmonella infection, S. typhimurium per-
sists predominately in the MLN and, to a lesser degree, in
the spleen and liver of chronically infected mice.
Anti-Salmonella IgG Antibody Titers. To determine
whether mice chronically infected with S. typhimurium
produced antibodies to the organism, serum was collected
from each mouse at the time of death, and anti-Salmonella
IgG antibody titers were determined by ELISA. All of the
infected mice had high antibody titers, with a 10-fold in-
crease between 60 and 140 d (Fig. 3). At 365 d, the anti-
body titers of serum from infected mice ranged from 102 to
105, which were all significantly higher than the age-
matched, uninfected control mice; however, the five mice
that had apparently cleared the infection had lower anti-
Salmonella antibody titers than the persistently infected
mice (Fig. 3).
Histology of Chronically Infected Tissues. Histopathologi-
cal studies were performed to examine the consequences of
chronic S. typhimurium infection on tissue integrity, inflam-
mation, and lesion formation. Histopathological lesions
were more frequent in the spleen, liver, and MLNs at 60 d
after oral inoculation than at 365 d (Fig. 4, A and B). The
tissues from mice infected for 60 d contained typical foci of
necrosis, microgranulomas, or accumulations of PMNs
(Fig. 4 C). At 140 d, discrete lesions were scarce in the liver
and spleen. These rare inflammatory foci consisted pre-
dominantly of macrophages with minimal central necrosis
(Fig. 4 D). By 365 d, the focal granulomas were not signif-
icantly different than 140 d, but they tended to have in-
creased numbers of lymphocytes and large mononuclear
Figure 3. Mean anti–S. typhimurium IgG titers in persis-
tently infected 129sv mice. S. typhimurium-infected (n   5
for days 60 and 140; n   4 for days 180 and 270; n   13
for day 365) and uninfected age-matched control mice
(n   3, except for day 180). Antibody titers were deter-
mined by ELISA using killed whole S. typhimurium sonicate
as antigen. (Closed diamonds) IgG titer in S. typhimu-
rium-infected mice. (Open triangles) IgG titer in unin-
fected controls. Each serum was tested at least three
times in triplicate.
Figure 4. Histology of infected tissues from mice persistently infected
with S. typhimurium. Liver and spleen sections were stained with hema-
toxylin and eosin. (A) Liver section from mouse infected for 60 d. Arrows
point to multiple areas of inflammation and microgranulomas. (B) Liver
section form mouse infected for 365 d. Arrow points to a focal granu-
loma. (C) Section of spleen infected for 60 d. Arrow shows accumulation
of PMN in red pulp. (D) Section of spleen infected for 140 d. Arrow
shows accumulation of macrophages. (E) Section of liver infected for 365 d.
Bars: (A and B) 0.1 mm; (C–E) 20  m.S. typhimurium Reactivation in Chronically Infected Mice 236
cells surrounding central areas of tightly opposed macro-
phages (Fig. 4 E).
S. typhimurium Persist in MOMA-2  MLN Macrophages.
The tissue colonization data of 129sv mice orally infected
with S. typhimurium indicated that during the initial stages
of infection, bacteria were found at high levels at multiple
sites throughout the mouse, but were beginning to be
cleared between 60 and 270 d after infection (Table I). The
bacteria persisted in a limited number of sites, predomi-
nately and invariably in the MLN, despite a strong anti-
body response.
We wished to determine the site of S. typhimurium per-
sistence in the MLN. To ensure that MLNs were taken
from mice still infected with wild-type S. typhimurium, we
monitored the course of infection in 129sv mice using a
noninvasive method that detects bacterial signal in live
animals in a semi-quantitative manner, IVIS (31). Mice
were infected with a wild-type strain of S. typhimurium,
SMB500, which constitutively expresses the genes neces-
sary for bioluminescent light production (41). This strain is
as virulent as wild-type SL1344 in the mouse model and
retains the bioluminescent genes in the mouse infection
model (unpublished data). By following the course of in-
fection in this noninvasive manner, we found that in a
given mouse, the bacterial load varied over time. For ex-
ample, Fig. 5 shows a mouse that has a higher biolumines-
cent signal at 23 d than at 40 d. 80 d after infection, the sig-
nal increased again. Three mice that were infected with S.
typhimurium for 80 d and had elevated bioluminescent sig-
nals were killed, and the MLNs from each mouse were fro-
zen and sectioned for immunohistochemistry.
To determine the host cells that S. typhimurium are asso-
ciated with in persistently infected MLN, we stained frozen
sections with several antibodies to host immune cells. Ini-
tially, we stained sections with an antibody that recognized
neutrophils, Gr-1, an anti-Salmonella antibody, and an anti-
body that nonspecifically stains the host cells. We found
that bacteria did not colocalize with neutrophils; rather,
they resided within large host cells that were surrounded by
neutrophils (Fig. 6 A). This finding and the results of our
histological staining led us to examine the remaining sec-
tions with an antibody that stains the cytoplasm of all mac-
rophages, MOMA-2. The bacteria were mainly found
colocalized with MOMA-2  macrophages in macrophage-
rich areas of the lymph nodes within the subcapsular sinus
Figure 5. Monitoring 129sv mice persistently infected with S. typhimurium
by an IVIS. 129sv mice were inoculated by oral administration of the
bioluminescent labeled wild-type S. typhimurium strain, SL1344hha::
Tn5lux at a dose of 108 CFU and monitored over 80 d. Days are indi-
cated in the top left corner of each image. Light intensity is represented
by a color scale in counts. Eight mice were inoculated and imaged on
days 7, 23, 40, and 80. The arrow points to a mouse 2, which showed
variable levels of signal over the 80 d. Mouse 4 died between 40 and 80 d.
The asterisk indicates mice that were killed for analysis of MLN by confocal
microscopy (e.g., mouse 2, 5, and 7).
Figure 6. S. typhimurium persist
inside of macrophages within the
MLN of chronically infected mice.
(A) MLN sections were labeled
with anti-Salmonella antibody
(green), antineutrophil antibody,
Gr-1 (red), and an anti–mouse
IgG antibody (blue) that nonspecifically stains other immune cells. (A,
D, and E) The image is a projection of a 20- m z-stack collected
through the 60  objective on a confocal microscope (model MRC-
600; Bio-Rad Laboratories). Arrow points to bacterium. Bar, 10  m.
(B) MLN sections were labeled with anti-Salmonella antibody (green),
antimacrophage antibody, MOMA-2 (red), and ToTo-3 to stain all
nuclei (blue). The image is a projection of a 15- m z-stack collected
through the 40  objective on a confocal microscope. (C) Volocity 2.0
was used to project the side view (yz) and bottom view (xz) of the
infected macrophage in B (represented by the xy view), which together
demonstrate the intracellular location of the bacterium. Bar, 5  m.
(D) Three-dimensional projection of macrophage in C. (E) MLN sec-
tions were labeled with anti-Salmonella antibody (green), antimacrophage
antibody (red), and B220 (blue), the anti–B lymphocyte antibody.
Bar, 10  m.Monack et al. 237
and outer cortex (Fig. 6 B). Further analysis of the z-stacks
obtained on the confocal microscope revealed that bacteria
were inside these macrophages, as seen in the xz, yz, and
three-dimensional projections (Fig. 6, C–E). To determine
the frequency with which S. typhimurium were located in-
side macrophages, we examined every bacterium found
within all sections and scored whether it was inside or out-
side a MOMA-2  host cell. 82% of the bacteria were
clearly intracellular, whereas the remaining bacteria were
either extracellular or their location was unclear (Table II).
We noted at the same time the number of bacteria residing
within the infected host cell and found that the mean num-
ber was between three and four bacteria per cell (Table II).
We further characterized the host immune cells in the foci
of bacterially infected macrophages and found that in addi-
tion to macrophages, the other immune cells in the vicinity
of infected macrophages were predominantly B lympho-
cytes (Fig. 6 E). Thus, S. typhimurium persist intracellularly
within macrophages of the MLN of 129sv mice.
IFN  Neutralization Causes Reactivation of Systemic S. ty-
phimurium Infection. The ability of Salmonella to survive
and/or replicate inside macrophages is dependent on the
activation state of the host cell, which can be affected by
host cytokines such as IFN . We wished to test the role of
IFN  in the persistent S. typhimurium mouse infection.
Mice that had been infected with S. typhimurium for 260 d,
and were not shedding, were injected intraperitoneally
with either an IFN  neutralizing antibody or an isotype-
matched control antibody. 3 wk after the initial injection
of the IFN  neutralizing antibody, three of the five mice
in this group began to show signs of illness such as ruffled
fur and malaise. At this time the mice were killed and dis-
sected for tissue counts. The levels of detectable S. typhi-
murium in the PP, spleen, liver, and gall bladder were vari-
able in the group of mice that received the neutralizing
antibody; however, all five of the mice that received the
neutralizing antibody were colonized in the MLN and
cecum and were shedding high levels of S. typhimurium
(2.3–7.8 logs per gram of feces; Fig. 7 A). In contrast, the
mice that received the control antibody were colonized at
low levels in the MLN, and only two were shedding lower
levels of S. typhimurium (1.6–2.9 logs per gram of feces;
Fig. 7 B). Furthermore, the tissues from mice that were
treated with IFN  neutralizing antibody contained lesions
in the spleen and liver that are typical of S. typhimurium in-
fection (Fig. 8 A). Surprisingly, the three mice that ap-
peared ill had epicarditis/pericarditis and pleuritis (Fig. 8, B
and C), and this inflammation was associated with the pres-
ence of S. typhimurium (Fig. 8, D and E). In contrast, the
same tissues from mice treated with the control antibody
did not contain inflammation in the heart or lungs (unpub-
lished data). Thus, we were able to reactivate the chroni-
cally carried S. typhimurium to cause an acute infection
even in the presence of anti-Salmonella antibody by inacti-
vating the host cytokine IFN .
Discussion
Some bacterial pathogens are capable of establishing per-
sistent infections in mammalian hosts despite activating in-
flammatory and antimicrobial responses (6, 42). For exam-
ple, Helicobacter pylori inhabits the human gastric mucosa,
Table II. S. typhimurium Localize to Macrophages in MLN from 
Persistently Infected 129sv Mice
Percentage of 
inside macrophagesa Mean No. bacteria/cell   SEb
82.43   1.19 3.89   1.14
aThe mean percentage of bacteria inside and standard error were calcu-
lated from serial sections stained with MOMA-2 antibody from three dif-
ferent mice. A minimum of 100 bacteria were counted from each mouse.
bThe mean number of bacteria per 20- m slice of a cell was calculated
from serial sections stained with MOMA-2 antibody from three differ-
ent mice.
Figure 7. Anti-IFN  neutralizing antibody reactivates S. typhimurium
replication in persistently infected mice. (A) Bacterial counts in tissues
from 129sv mice infected for 260 d and injected with IFN  neutralizing
antibody. (B) Bacterial counts in tissues from 129sv mice infected for 260 d
and injected with isotype control antibody. The x axis is the tissue
where F   feces, C   cecum, PP   Peyer’s patches, M   mesenteric
LNs, S   spleen, L   liver, G   gall bladder. The y axis denotes individual
mice. The z axis is the CFU per gram of tissue. The Mann-Whitney U
test was performed for statistical significance comparing the bacterial load
from anti-IFN  neutralizing antibody–treated mice with control antibody-
treated mice. *, P   0.05; **, P   0.01.S. typhimurium Reactivation in Chronically Infected Mice 238
and persistence can be lifelong (42). Mycobacterium tuberculosis
persists inside alveolar macrophages within lung granulomas
of infected humans for years and will sometimes reactivate
to cause an acute infection (42). Chlamydiae, obligate intra-
cellular bacterial pathogens, also cause persistent infections
despite activating the host immune system (43). S. typhi
causes systemic infection (typhoid fever) that involves colo-
nization of the RES. Some S. typhi–infected individuals be-
come lifelong carriers, periodically shedding high numbers
of bacteria in their stools. Because S. typhi only colonizes
humans, it has been suggested that these chronic carriers are
the reservoir of S. typhi and that perhaps the carrier state is
the ultimate and essential goal of S. typhi infection (44).
Thus, we set out to establish a persistent Salmonella infection
in mice and to characterize this model.
The laboratory mouse has been used as a model for acute
systemic Salmonella infections, and early studies with classi-
cal, well-characterized inbred strains of mice have contrib-
uted substantially to our understanding of host–pathogen
interactions. However, most of these studies have focused
on infections of highly susceptible strains of mice, strains
that carry a mutant Nramp1 allele. Nramp1 has been shown
to be very important for controlling the exponential
growth of Salmonella during the early phase of systemic in-
fections; inbred strains of mice carrying mutant Nramp1 al-
leles either die from low doses of Salmonella or clear the in-
fection after  30 d (1, 18). Thus, it is difficult to study the
pathogenesis of persistent Salmonella infection in these
strains of mice. We describe here a model for persistent in-
fection of a strain of mice that carries a wild-type Nramp1
allele (129sv) using wild-type S.  typhimurium. We have
shown that, after oral infection of 129sv mice, which re-
sulted in systemic infection, the period of recovery was
characterized by long-term persistence of S. typhimurium in
low numbers in the MLNs.
Some Salmonella serotypes such as S. typhi, S. dublin, and
S. pullorum may, after clinical disease or asymptomatic in-
fection, persist in the body for long periods of time. In the
case of S. typhi and S. dublin, long-term excretion of the
bacteria has classically been interpreted to represent local-
ization to and chronic infection of the gall bladder (40, 45,
46). Even though humans that chronically carry S. typhi of-
ten have biliary tract disease, its presence is not an absolute
requirement for development of the carrier state (10, 40). A
previous study in primates demonstrated that S. typhi was
carried exclusively in MLN at 50 d after an oral infection of
chimpanzees (47). In the case of S. pullorum, it was recently
shown that bacteria are carried in the spleen and reproduc-
tive tract, specifically the ovary and oviduct of hens (48).
Our data suggest that the site of chronic carriage of S. ty-
phimurium in mice is the MLN and not the gall bladder.
However, we did find that all of the mice that were shed-
ding S. typhimurium at the time of death (n   5) were colo-
nized in the gall bladder as well as the liver (Table I). Per-
haps the true reservoir of persistent bacterial carriage even
in humans is the MLN, and some change in host immune
status leads to spread from the RES to the liver and gall
bladder, which in turn leads to reseeding of the intestine
and fecal shedding as is seen during a primary infection.
Although the site of Salmonella proliferation in suscepti-
ble strains of mice has been shown to be within macro-
phages in the spleen and liver (49, 50), the location of S. ty-
phimurium persistence during chronic infection had not
been determined previously. Our tissue colonization data
indicated that viable bacteria were consistently isolated
from MLN of persistently infected mice. We show here by
microscopy of immunohistochemically stained tissue sec-
tions that 82% of the persisting bacteria reside inside mac-
rophages within the MLN. We cannot say that all of the
bacteria detected with our anti–S. typhimurium antibody are
Figure 8. Histology of infected tissues from mice
persistently infected with S. typhimurium and treated
with IFN  neutralizing antibody. (A) Liver, (B) lung,
and (C) heart. Sections were stained with hematoxylin
and eosin from a mouse infected for 260 d followed by
3 wk of IFN  neutralizing antibody. (A) Arrow points
to area of inflammation and microgranulomas. (B) Arrow
points to inflammation in the pleura. (C) Arrow points
to inflammation covering the epicardium. (D) Liver
and (E) heart. Bacteria in sites of inflammation from serial
sections were stained with antibody to S. typhimurium
(green), actin was stained with phalloidin-Alexa594
(red), and nuclei of host cells were stained with Toto-3
(blue). (D) Arrow points to bacterium in the center of
lesion. (Inset) Enlargement of the area of lesion containing
the bacterium. (E) Arrow points to bacterium in the
epicardium. (Inset) Enlargement of the area. Bars: (A)
20  m; (B and C) 200  m; (D and E) 100  m.Monack et al. 239
viable; however, the large percentage of bacteria residing
inside macrophages certainly suggests that this population
serves as the persistent reservoir of S. typhimurium. Further-
more, bacteria were able to persist in the presence of high
levels of circulating specific antibody against S. typhimu-
rium. Thus, although an effective antibody response is gen-
erated and is likely to be important in clearing extracellular
bacteria, the intracellular bacteria can survive the host’s in-
nate and adaptive immune defenses for as long as a year in
60% of the mice.
The fate of macrophages persistently infected with S. ty-
phimurium is not known. It is possible that bacteria persist
within macrophages for the lifetime of the host cell, and
then infect a new macrophage. However, S. typhimurium is
able to induce host cell death in vivo (49, 51). S. typhimu-
rium mediates macrophage death by at least two mecha-
nisms. One mechanism involves a very rapid macrophage
death that requires the type III secretion system (TTSS) en-
coded on Salmonella pathogenicity island (SPI) 1, (52). S.
typhimurium can also induce macrophage death that occurs
 18 h after infection. This delayed macrophage death re-
quires a second TTSS that is encoded on SPI 2 and is used
inside host cells (53, 54). Perhaps the dead or dying macro-
phages containing S. typhimurium are phagocytosed by
macrophages that are recruited to the site of infection and
serve as a safe haven for Salmonella to survive while avoid-
ing extracellular host defenses.
The high antibody titer that we found at 365 d after in-
fection in the mice where S. typhimurium was recovered in-
dicates that the continued presence of bacteria is needed for
this high sustained humoral response and that the immune
response has not been totally abrogated. Perhaps the hu-
moral response participates in keeping the number of bac-
teria inside each macrophage lower in our persistent S. ty-
phimurium model compared with what has been reported in
previous studies of acute infections (50). In this work, we
did not determine whether antibodies to specific S. ty-
phimurium antigens correlated with differences in those ani-
mals that eventually clear the infection as compared with
those that continue to be persistently infected; this is one
goal in our ongoing investigation. However, the adaptive
immune response also provides a positive feedback to the
innate immune system through the synthesis of cytokines
that either increase effector cell numbers or activate these
cells for an increased antibacterial performance.
Once activated T cells are present, they provide the
macrophage-activating factor IFN . This type II inter-
feron acts in concert with bacterial components (e.g., LPS)
to generate macrophages with a maximal capacity to ingest
and kill bacteria (55). IFN  has been shown to be impor-
tant for the maintenance of the latent state in the M. tuber-
culosis mouse model of infection as well as the latent state
of Chlamydia trachomatis in cell culture (43, 56). Previous
studies of the role of IFN  in the acute Salmonella mouse
infection have shown that IFN  plays a role in controlling
the early phase of Salmonella replication, but is not neces-
sary for bacterial clearance (57–59). We tested the role of
IFN  in the persistent S. typhimurium infection in mice by
neutralizing this cytokine in chronically infected mice.
Mice infected with S. typhimurium for 260 d showed no
signs of illness before IFN  neutralization. However,
within 3 wk after treatment with the IFN  neutralizing
antibody, three out of five mice began to show signs of
acute illness, and upon dissection for organ bacterial
counts showed very high levels of S. typhimurium in some
of the tissues compared with the group of mice that re-
ceived the control antibody. Although the levels of bacte-
ria isolated from the MLN, spleen, liver, and gall bladder
of the mice injected with the neutralizing antibody were
relatively low, all of these mice were colonized in the
cecum, and four of the five mice were colonized in the
PP. The role of IFN  in colonization of the gastrointesti-
nal tract relative to RES colonization is unclear. Perhaps
the increased bacterial load in the gastrointestinal tract is
due to a difference in the access of circulating antibodies
within the RES compared with PP and cecum. Perhaps
when intracellular bacteria are released they are killed by
antibody-mediated killing, thus keeping the levels in the
organs low. In contrast, the antibody-mediated killing
does not occur in the intestine, allowing high levels of S.
typhimurium replication. An alternate explanation for these
data is that the high level of gastrointestinal colonization
reflects reinfection of the PP and cecum upon ingestion of
contaminated feces. We found that the levels of S. typhi-
murium recovered from the gall bladders of the anti–
IFN -treated mice were very low. It is unclear why the
classic explanation that fecal shedding represents contami-
nation from the infected gall bladder does not seem to be
borne out in our IFN  neutralization results. We also
found that three of the mice treated with the neutralizing
antibody had pericarditis and pleuritis, which was associ-
ated with the presence of S. typhimurium in the thoracic
exudates in these animals, likely indicating that the reacti-
vation of a systemic infection led to colonization of distant
sites in three of the treated mice. Salmonella spp. have been
associated with cardiac infections in humans, typically oc-
curring in people with underlying heart disease (60, 61);
perhaps we are reproducing this situation in the treated
mice. Our data indicate that IFN  plays a role in main-
taining the balance in the immune status of persistently in-
fected mice, perhaps by stimulating the infected macro-
phage to suppress bacterial replication.
Previous studies have shown that S. typhimurium may
limit the in vivo proliferation of CD4  and CD8  T cells
despite their activated phenotype (36). Additionally, it has
been shown that active S. typhimurium infection induces im-
munosuppression in mice and causes the production of large
amounts of IL-10 and nitric oxide, which are both known
immunosuppressive compounds (58, 62–64). We believe
that Salmonella is not an innocent bystander in maintaining
the balance between clearance and persistence. In this re-
gard, Salmonella may play an active role in modulating or
even directly manipulating the host responses, thereby pre-
venting clearance of intracellular S. typhimurium.S. typhimurium Reactivation in Chronically Infected Mice 240
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